J Vet Sci. 2007 Dec;8(4):353-356   
 

Clinical pharmacokinetics of norfloxacin-glycine acetate after intravenous and oral administration in pigs

Zhi-Qiang Chang1, Byung-Chol Oh2, Jong-Choon Kim3, Kyu-Shik Jeong1, Myung-Heon Lee4, Hyo-In Yun5, Mi-Hyun Hwang1, Seung-Chun Park1,*

 

1College of Veterinary Medicine, Kyungpook National University, Daegu 702-701, Korea
2Lee Gil Ya Cancer and Diabetes Institute, Gachon University of Medicine and Science, Incheon 406-840, Korea
3College of Veterinary Medicine, Chonnam National University, Kwangju 500-757, Korea
4National Veterinary Research and Quarantine Service, Anyang 430-824, Korea
5College of Veterinary Medicine, Chungnam National University, Daejeon 302-305, Korea

* parksch@knu.ac.kr

 

The pharmacokinetics and dosage regimen of norfloxacin- glycine acetate (NFLXGA) was investigated in pigs after a single intravenous (i.v.) or oral (p.o.) administration at a dosage of 7.2 mg/kg body weight. After both i.v. and p.o. administration, plasma drug concentrations were best fitted to an open two-compartment model with a rapid distribution phase. After i.v. administration of NFLXGA, the distribution (t1/2¥á) and elimination half-life (t1/2¥â) were 0.36 ¡¾ 0.07 h and 7.42 ¡¾ 3.55 h, respectively. The volume of distribution of NFLXGA at steady state (Vdss) was 4.66 ¡¾ 1.39 l/kg. After p.o. administration of NFLXGA, the maximal absorption concentration (Cmax) was 0.43 ¡¾ 0.06 ¥ìg/ ml at 1.36 ¡¾ 0.39 h (Tmax). The mean absorption (t1/2ka) and elimination half-life (t1/2¥â) of NFLXGA were 0.78 ¡¾ 0.27 h and 7.13 ¡¾ 1.41 h, respectively. The mean systemic bioavailability (F) after p.o. administration was 31.10 ¡¾ 15.16%. We suggest that the optimal dosage calculated from the pharmacokinetic parameters is 5.01 mg/kg per day i.v. or 16.12 mg/kg per day p.o.